Related Experiment Video
Updated: Aug 14, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Generation of mutator mutants during carcinogenesis
Ranga N Venkatesan1, Jason H Bielas, Lawrence A Loeb
1Department of Pathology, University of Washington, Seattle, WA 98195-7705, USA.
DNA Repair
|December 20, 2005
Summary
Cancer develops from pre-cancer cells acquiring numerous mutations. This study extends the mutator phenotype hypothesis, highlighting how random point mutations from replication errors and DNA damage drive carcinogenesis.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Normal cells rarely accumulate mutations, while tumors exhibit extensive mutations.
- The
- mutator phenotype
- hypothesis explains pre-cancer cell mutation accumulation during carcinogenesis.
Purpose of the Study:
- Extend the
- mutator phenotype
- hypothesis.
- Highlight emerging pathways generating genome-wide random mutations.
- Emphasize random point mutations driving carcinogenesis.
Main Methods:
- Review of biochemical activities leading to genome-wide mutations.
- Focus on specific mutation-generating pathways: replication errors, oxidative damage, enzymatic modifications, and abasic sites.
Main Results:
- Aberrant biochemical activities can lead to genome-wide random mutations.
- Replication errors, oxidative base damage, covalent base modifications, and abasic sites are key sources of mutations.
- These simple random point mutations are sufficient to drive carcinogenesis.
Conclusions:
- The extended
- mutator phenotype
- hypothesis provides a framework for understanding carcinogenesis.
- Emerging pathways generating random point mutations are critical drivers of cancer development.
- Targeting these mutation-generating mechanisms may offer novel therapeutic strategies.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
01:39Mutations
Overview
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...